BrightView Holdings, Inc., through its subsidiaries, provides commercial landscaping services in the United States. It operates in two segments, Maintenance Services and Development Services. The Maintenance Services segment delivers a suite of recurring commercial landscaping services, including mowing, gardening, mulching and snow removal, water management, irrigation maintenance, tree care, golf course maintenance, and specialty turf maintenance. Its customers' properties include corporate and commercial properties, homeowners associations, public parks, hotels and resorts, airport authorities, municipalities, hospitals and other healthcare facilities, educational institutions, restaurants and retail, and golf courses. This segment's customer base includes approximately 11,700 office parks and corporate campuses 10,000 residential communities, and 700 educational institutions. The Development Services segment offers landscape architecture and development services for new facilities and redesign projects. Its services include project design and management services, landscape architecture and installation, irrigation installation, tree moving and installation, pool and water features, sports field, and other services. BrightView Holdings, Inc. also operates as official field consultant to Major League Baseball. The company was formerly known as BrightView Acquisition Holdings, Inc. BrightView Holdings, Inc. was founded in 1939 and is headquartered in Blue Bell, Pennsylvania.

BrightView Holdings, Inc.

Abbvie ($ABBV) announced an update on their ongoing clinical study. AbbVie (ABBV) is expanding its push into Alzheimer’s with a new study titled “A...

AbbVie Steps Deeper Into Alzheimer’s: What the ABBV-1758 Trial Means for Investors

In a report released today, Manuela Stuerzer from Deutsche Bank maintained a Buy rating on verbio Vereinigte BioEnergie, with a price target of €42...

Deutsche Bank  Keeps Their Buy Rating on verbio Vereinigte BioEnergie (0NLY)

Barak Valley Cements Limited ( ($IN:BVCL) ) has shared an announcement. Barak Valley Cements Limited has released its unaudited financial results f...

Barak Valley Cements Publishes Q1 FY27 Unaudited Results in Line with SEBI Norms

An announcement from Bravura Solutions Limited ( ($AU:BVS) ) is now available. Bravura Solutions has announced senior leadership changes, with form...

Bravura Solutions Reshapes Finance and Governance Leadership

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Liquidia Technologies (LQDA), AbbVie (ABBV) and Esta...

Analysts Offer Insights on Healthcare Companies: Liquidia Technologies (LQDA), AbbVie (ABBV) and Establishment Labs Holdings (ESTA)

In a report released yesterday, Cameron Halkett from Canaccord Genuity maintained a Buy rating on Bravura Solutions Limited, with a price target of...

Canaccord Genuity Reaffirms Their Buy Rating on Bravura Solutions Limited (BVS)

Shaw and Partners analyst Jules Cooper maintained a Buy rating on Bravura Solutions Limited today and set a price target of A$3.30. According to Ti...

Bravura Solutions Limited (BVS) Receives a Buy from Shaw and Partners

In a report released today, from Macquarie maintained a Hold rating on Bravura Solutions Limited, with a price target of A$3.30. Bravura Solutions ...

Macquarie Sticks to Their Hold Rating for Bravura Solutions Limited (BVS)

Abivax SA ( ($FR:ABVX) ) has provided an update. Abivax reported that as of July 31, 2026, its share capital consists of 87,253,797 shares, corresp...

Abivax Updates Share Capital and Voting Rights as of July 31, 2026

Abbvie ($ABBV) announced an update on their ongoing clinical study. AbbVie’s phase 3 study, BOTOX® (onabotulinumtoxinA) for the Reduction of Masset...

AbbVie’s BOTOX Jawline Trial Wraps Up: What the Masseter Study Means for ABBV Investors

Abbvie ($ABBV) announced an update on their ongoing clinical study. AbbVie’s latest update covers a completed early study testing venetoclax with a...

AbbVie’s Venetoclax Combo in High-Risk MDS: What a Fresh Trial Update Signals for Investors

Banco Bilbao ( ($BBVA) ) has provided an update. BBVA has provided an update on the execution of the first tranche of its share buyback programme, ...

BBVA Advances First Tranche of Share Buyback Programme

Banco Bilbao Vizcaya Argentaria ( ($ES:BBVA) ) has shared an update. BBVA has released a periodic report on its ongoing share buyback program, disc...

BBVA Publishes Periodic Report on Share Buyback Program

Hub Girisim Sermayesi Yatirim Ortakligi A.S. ( ($TR:HUBVC) ) has shared an update. Hub Girisim Sermayesi Yatirim Ortakligi A.S. has reported that a...

Hub Girisim Discloses High Share of Non-Compliant Assets Under Participation Finance Rules

Abbvie ($ABBV) announced an update on their ongoing clinical study. AbbVie (ABBV) has launched a Phase 2 dose‑finding study titled “A Phase 2 Dose-...

AbbVie Targets Obesity Market With New Phase 2 ABBV-295 Trial

There’s a lot to be optimistic about in the Consumer Cyclical sector as 2 analysts just weighed in on Breville Group (BVILF) and Airbnb (ABNB) with...

Analysts Offer Insights on Consumer Cyclical Companies: Breville Group (OtherBVILF) and Airbnb (ABNB)

Itau Unibanco ( ($ITUB) ) has provided an announcement. Itaú Unibanco Holding S.A., a Brazilian universal bank headquartered in São Paulo, operates...

Itaú Unibanco Updates 2025 Reference Form, Highlighting Ongoing Strategic Shift

In a report released today, Greg Palm from Craig-Hallum reiterated a Buy rating on BrightView Holdings, with a price target of $15.00. According to...

Craig-Hallum Sticks to Its Buy Rating for BrightView Holdings (BV)

Goldman Sachs analyst Sofie Peterzens maintained a Buy rating on Banco Bilbao Vizcaya Argentaria yesterday and set a price target of €27.20. The co...

Goldman Sachs Remains a Buy on Banco Bilbao Vizcaya Argentaria (BVA)

Berenberg Bank analyst Luisa Hector maintained a Buy rating on AbbVie yesterday and set a price target of $275.00. The company’s shares closed yest...

AbbVie (ABBV) Gets a Buy from Berenberg Bank

AbbVie ( ($ABBV) ) has issued an update. On August 4, 2026, AbbVie entered into an underwriting agreement with a syndicate of major banks to issue ...

AbbVie prices $9.9B senior notes to fund acquisition

Analysts fell to the sidelines weighing in on BrightView Holdings (BV) and BWX Technologies (BWXT) with neutral ratings, indicating that the expert...

Analysts’ Top Industrial Goods Picks: BrightView Holdings (BV), BWX Technologies (BWXT)

Deutsche Bank analyst Manuela Stuerzer maintained a Buy rating on verbio Vereinigte BioEnergie today and set a price target of €42.00. According to...

Deutsche Bank  Reaffirms Their Buy Rating on verbio Vereinigte BioEnergie (0NLY)

Bellavista Resources Ltd ( ($AU:BVR) ) just unveiled an announcement. Bellavista Resources Ltd, an ASX-listed explorer, is focused on gold projects...

Bellavista Advances Gold Drilling in Canada and Australia, Backed by Strong Cash Position

Bravura Solutions Limited ( ($AU:BVS) ) has issued an announcement. Bravura Solutions Limited has scheduled an analyst and investor briefing to coi...

Bravura Sets Investor Briefing for FY26 Results Release

Claranova SA ( ($FR:ALCLA) ) has provided an announcement. Claranova SE has disclosed its latest share capital and voting rights figures as of July...

Claranova Updates Share Capital and Voting Rights Structure

Abbvie ($ABBV) announced an update on their ongoing clinical study. AbbVie is running a late-stage study called “A Phase 3 Randomized, Open Label, ...

AbbVie’s ABBV-706 Lung Cancer Trial: A New Late-Stage Bet in Small Cell Oncology

BULBULOGLU VINC SANAYI VE TICARET A.S. ( ($TR:BVSAN) ) has shared an announcement. Bulbuloglu Vinc Sanayi ve Ticaret A.S. has signed a new contract...

Bulbuloglu Vinc Wins €5.1 Million Bridge Contract for Overseas Project

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Viking Therapeutics (VKTX), AbbVie (ABBV) and Cenc...

Analysts Offer Insights on Healthcare Companies: Viking Therapeutics (VKTX), AbbVie (ABBV) and Cencora (COR)

Abbvie ($ABBV) announced an update on their ongoing clinical study. AbbVie (ABBV) is running a new observational study called “A Concordance Study ...

AbbVie Targets Ovarian Cancer Biomarkers With New FRa Concordance Study

Abbvie ($ABBV) announced an update on their ongoing clinical study. AbbVie (ABBV) is running a global Phase 2/3 study called “A Randomized Phase 2/...

AbbVie’s New AML Combo Trial Aims to Boost Its Oncology Pipeline

In a report released today, Nick Maxwell from PAC Partners maintained a Buy rating on Advanced Braking Technology Limited, with a price target of A...

Advanced Braking Technology Limited (ABV) Receives a Buy from PAC Partners

DBV Technologies ( ($FR:DBV) ) has provided an update. DBV Technologies has raised approximately $50 million through the sale of new American Depos...

DBV Technologies Raises $50 Million via Nasdaq ATM Share Sale

Abivax SA ( ($FR:ABVX) ) has issued an update. Abivax has received a positive response from the U.S. Food and Drug Administration following its pre...

Abivax Gains FDA Alignment on Obefazimod NDA Plan for Ulcerative Colitis

There’s a lot to be optimistic about in the Consumer Goods sector as 2 analysts just weighed in on Unilever (UL) and Arca Continental SAB de C V (E...

Analysts Are Bullish on These Consumer Goods Stocks: Unilever (UL), Arca Continental SAB de C V (EMBVF)

Bank of America Securities analyst Antonio Reale maintained a Hold rating on Banco Bilbao Vizcaya Argentaria today and set a price target of €25.00...

Bank of America Securities Sticks to Their Hold Rating for Banco Bilbao Vizcaya Argentaria (BVA)

An update from Baronsmead Venture ( ($GB:BVT) ) is now available. Baronsmead Venture Trust PLC, a UK venture capital trust offering tax-efficient e...

Baronsmead Venture Trust Plans New Subscription Offer for 2026/27

The latest update is out from BULBULOGLU VINC SANAYI VE TICARET A.S. ( ($TR:BVSAN) ). JCR Eurasia Rating has affirmed Bulbuloglu Vinc Sanayi ve Tic...

Bulbuloglu Vinc’s AA- Rating Affirmed With Stable Outlook by JCR Eurasia

In a report released today, Arthur Truslove from Citi maintained a Hold rating on Bureau Veritas, with a price target of €31.44. Truslove covers th...

Citi Keeps Their Hold Rating on Bureau Veritas (0MH1)

An update from Advanced Braking Technology Limited ( ($AU:ABV) ) is now available. Advanced Braking Technology reported record product sales revenu...

Advanced Braking Technology posts record quarter as mining demand fuels global expansion

An update from Banco Bilbao Vizcaya Argentaria ( ($ES:BBVA) ) is now available. BBVA has announced a renewal of its leadership team aimed at drivin...

BBVA Overhauls Leadership Team to Support New Era of Transformation

Top Glove Bhd ( ($TPGVF) ) has issued an update. Malaysia’s pension fund Kumpulan Wang Persaraan (Diperbadankan) has reduced its indirect stake in ...

KWAP Trims Indirect Stake in Top Glove, Retains Major Holding

In a report released today, Emily Field from Barclays maintained a Buy rating on AbbVie, with a price target of $300.00. According to TipRanks, Fie...

Barclays Reaffirms Their Buy Rating on AbbVie (ABBV)

The latest announcement is out from Bellavista Resources Ltd ( ($AU:BVR) ). Bellavista Resources has begun diamond drilling at the Pickle Crow Gold...

Bellavista accelerates Canadian gold push with Pickle Crow drilling and strategic capital raise

Morgan Stanley analyst Chenny Wang maintained a Buy rating on Breville Group today and set a price target of A$38.20. Wang covers the Consumer Cycl...

Morgan Stanley Sticks to Their Buy Rating for Breville Group  (BVILF)

The latest update is out from Banco Bilbao ( ($BBVA) ). BBVA has reported progress on the third tranche of its ongoing share buyback program, execu...

BBVA Nears Completion of Third Share Buyback Tranche

Banco Bilbao ( ($BBVA) ) just unveiled an announcement. BBVA plans to fully redeem its mortgage covered bond issue “Cédulas Hipotecarias – Febrero ...

BBVA to Fully Redeem €1.5 Billion Mortgage Covered Bonds Early

Abbvie ($ABBV) announced an update on their ongoing clinical study. AbbVie’s first-in-human Phase 1 trial, officially titled “A First-In-Human Stud...

AbbVie’s ABBV-722 Phase 1 Milestone: What Early Safety Data Means for Investors

Abbvie ($ABBV) announced an update on their ongoing clinical study. AbbVie has completed a real-world study called “Real-world Effectiveness and Tr...

AbbVie Wraps Up Real-World RINVOQ Study in Psoriatic Arthritis: What Investors Should Watch

Banco Bilbao Vizcaya Argentaria ( ($ES:BBVA) ) just unveiled an announcement. BBVA has announced a significant corporate event related to a shares ...

BBVA Announces Share Buyback Program as Part of Capital Management Strategy

There’s a lot to be optimistic about in the Consumer Goods sector as 2 analysts just weighed in on Arca Continental SAB de C V (EMBVF) and Loblaw C...

Analysts Offer Insights on Consumer Goods Companies: Arca Continental SAB de C V (OtherEMBVF) and Loblaw Companies (OtherLBLCF)

Stocks ended the week mixed as strength in blue-chip shares offset losses in technology and semiconductor stocks. The Dow Jones Industrial Average ...

The Week That Was, The Week Ahead: Macro and Markets, July 26

Abbvie ($ABBV) announced an update on their ongoing clinical study. AbbVie has launched a new Phase 1 study called “A Phase 1, Randomized, Double-B...

AbbVie’s ABBV-313 Phase 1 Trial: What Early Safety Work Means for Investors

In a report released today, Marta Sanchez Romero from J.P. Morgan maintained a Buy rating on Banco Bilbao Vizcaya Argentaria, with a price target o...

J.P. Morgan Sticks to Their Buy Rating for Banco Bilbao Vizcaya Argentaria (BVA)

Barclays analyst Benjamin Theurer maintained a Buy rating on Arca Continental SAB de C V today and set a price target of peso235.00. Theurer covers...

Barclays Reaffirms Their Buy Rating on Arca Continental SAB de C V (EMBVF)

Arca Continental (($MX:AC)) has held its Q2 earnings call. Read on for the main highlights of the call. Arca Continental’s latest earnings call pai...

Arca Continental Earnings Call Highlights Resilient Margins

An update from Abivax SA ( ($FR:ABVX) ) is now available. Abivax has reinforced its commercial organization with four senior hires covering global ...

Abivax bolsters commercial leadership ahead of potential U.S. launch of obefazimod

Banco Bilbao ( ($BBVA) ) has shared an update. BBVA has scheduled the presentation of its second quarter 2026 financial results for July 30, 2026, ...

BBVA Schedules Online Presentation of Q2 2026 Results

Top Glove Bhd ( ($TPGVF) ) has issued an announcement. Top Glove has reported a change in the interest of a substantial shareholder, Kumpulan Wang ...

KWAP Adjusts Substantial Shareholding in Top Glove

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Integer Holdings (ITGR), Thermo Fisher (TMO) and A...

Analysts Offer Insights on Healthcare Companies: Integer Holdings (ITGR), Thermo Fisher (TMO) and AbbVie (ABBV)

Top Glove Bhd ( ($TPGVF) ) has provided an announcement. Malaysia’s pension fund Kumpulan Wang Persaraan (Diperbadankan) has reported changes in it...

Malaysia’s Pension Fund Adjusts Substantial Stake in Top Glove

The latest update is out from Banco Bilbao ( ($BBVA) ). BBVA is a leading Spanish banking group in the financial services sector, providing retail ...

BBVA Nears Completion of Third Tranche in Share Buyback Program

Banco Bilbao ( ($BBVA) ) just unveiled an update. BBVA has provided an update on the execution of the third tranche of its share buyback programme,...

BBVA Nears Completion of Third Tranche in Share Buyback Programme

Above Food Ingredients ( ($ABVEF) ) has provided an update. Above Food Ingredients Inc., which currently trades over the counter under the symbol A...

Above Food Engages Counsel as It Appeals Nasdaq Delisting Over Filing Delays

Abbvie ($ABBV) announced an update on their ongoing clinical study. AbbVie’s latest Phase 1 update centers on how its drug ABBV-8736 moves through ...

AbbVie’s ABBV-8736 Injection Study Signals Quiet But Meaningful Pipeline Progress

Barclays analyst Cecilia Romero maintained a Hold rating on Banco Bilbao Vizcaya Argentaria today and set a price target of €23.60. According to Ti...

Barclays Keeps Their Hold Rating on Banco Bilbao Vizcaya Argentaria (BVA)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on DBV Technologies SA – American (DBVT) and Kalaris Th...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	BV	$11.74	0.00%	1.02M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	BV	$11.74	0%	1.02M
3
4
5
6

BV

Get BrightView Holdings, Inc. Data in Excel

Get BrightView Holdings, Inc. Data in Excel